Skip to main content
. Author manuscript; available in PMC: 2022 Dec 8.
Published in final edited form as: Adv Cell Gene Ther. 2022 Mar 20;2022:6807904. doi: 10.1155/2022/6807904

Figure 3:

Figure 3:

Liver weights vary while spleen weights trend heavier in rAAV-injected C57BL/6 Mice. (a) Endpoint liver weights of C57 mice. ANOVA p = 0.4017. (b) Endpoint spleen weights. ANOVA p = 0.4182. N = 7 for all groups except CB-PolyA (N = 14). (c) Liver : spleen weight ratios of C57BL/6 mice injected with rAAVs. Ratios reflect variability of the organs’ weights but are all similar. Kruskal-Wallis p = 0.0595. (d, e) Clot times via APTT of C57BL/6 mice injected with various rAAVs at day 90 and 194 postinjection. N = 14 for CB-PolyA, N = 7 for all other groups. ANOVA tests performed for (d) and (e).